Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of <131>I-Metaiodobenzyguanidine (<131>I-MIBG) Therapy for Patients With MIBG Avid Tumors

NCT02378428 is registered in ClinicalTrials.gov with Nationwide Children's Hospital as lead sponsor.

NCT NCT02378428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02378428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of <131>I-Metaiodobenzyguanidine (<131>I-MIBG) Therapy for Patients With MIBG Avid Tumors
Lead sponsor
Nationwide Children's Hospital
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 1, 2014
Completion date
December 31, 2025
Enrollment
65 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mibg avid tumors